Business Description
IO Biotech Inc
NAICS : 325412
SIC : 2834
ISIN : US4497781090
Total Employee Number:
78Description
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.69 | |||||
Equity-to-Asset | 0.02 | |||||
Debt-to-Equity | 19.89 | |||||
Debt-to-EBITDA | -0.2 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 54.8 | |||||
3-Year EPS without NRI Growth Rate | 56.7 | |||||
3-Year FCF Growth Rate | 49 | |||||
3-Year Book Growth Rate | -54 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 33.74 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 13.7 | |||||
9-Day RSI | 25.78 | |||||
14-Day RSI | 32.12 | |||||
3-1 Month Momentum % | 27.08 | |||||
6-1 Month Momentum % | -97.9 | |||||
12-1 Month Momentum % | -99.73 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.01 | |||||
Quick Ratio | 2.01 | |||||
Cash Ratio | 1.67 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -31.7 | |||||
Shareholder Yield % | -7352.08 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -297.46 | |||||
ROA % | -154.64 | |||||
ROIC % | -1170.66 | |||||
3-Year ROIIC % | -864.75 | |||||
ROC (Joel Greenblatt) % | -4075.46 | |||||
ROCE % | -231.38 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 0.02 | |||||
Price-to-Tangible-Book | 0.02 | |||||
EV-to-EBIT | 0.14 | |||||
EV-to-EBITDA | 0.14 | |||||
EV-to-Forward-Revenue | 0.69 | |||||
EV-to-FCF | 0.15 | |||||
Earnings Yield (Greenblatt) % | 714.29 | |||||
FCF Yield % | -579035.71 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:IOBTQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
IO Biotech Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.35 | ||
| Beta | -0.0137 | ||
| 3-Year Sharpe Ratio | -0.09 | ||
| 3-Year Sortino Ratio | -0.16 | ||
| Volatility % | 283.59 | ||
| 14-Day RSI | 32.12 | ||
| 14-Day ATR ($) | 0.00158 | ||
| 20-Day SMA ($) | 0.003316 | ||
| 12-1 Month Momentum % | -99.73 | ||
| 52-Week Range ($) | 0.0002 - 2.79 | ||
| Shares Outstanding (Mil) | 71.95 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
IO Biotech Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
IO Biotech Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 103 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 12 days | ||
| General meeting for 2026 | 2026-08-07 08:30 | In 6 days | ||
| First quarter earnings results for 2026 | 2026-07-31 | 0.00 (+0.00%) | ||
| Piper Sandler 36th Annual Healthcare Conference | 2025-12-03 15:00 | 0.63 (-7.37%) | ||
| 8 th Annual Evercore Healthcare Conference | 2025-12-02 07:55 | 0.68 (-5.28%) | ||
| Global Healthcare Conference | 2025-11-18 15:00 | 0.66 (-17.42%) | ||
| Third quarter earnings results for 2025 | 2025-11-14 | 0.81 (-3.46%) | ||
| H.C. Wainwright 27th Annual Global Investment Conference | 2025-09-10 08:00 | 1.80 (+1.69%) | ||
| Morgan Stanley 23rd Annual Global Healthcare Conference | 2025-09-09 07:45 | 1.80 (-9.68%) |
Show
Entries
IO Biotech Inc Frequently Asked Questions
What is IO Biotech Inc(IOBTQ)'s stock price today?
The current price of IOBTQ is $0.00. The 52 week high of IOBTQ is $2.79 and 52 week low is $0.00.
When is next earnings date of IO Biotech Inc(IOBTQ)?
The next earnings date of IO Biotech Inc(IOBTQ) is 2026-08-14 Est..
Does IO Biotech Inc(IOBTQ) pay dividends? If so, how much?
IO Biotech Inc(IOBTQ) does not pay dividend.
Guru Commentaries on OTCPK:IOBTQ
No articles.
Articles on IO Biotech Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers